Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-377-0 | CAS number: 811-97-2
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In accordance with section 2 of REACH Annex XI, the study on skin sensitisation need not be condcuted as the substance is a gas. In a non-standard study, Guinea pigs received one single intradermal injection of Freund's complete adjuvant followed by 7 occlusive epicutaneous administrations of 0.5 ml of liquefied HFC-134a, which was applied to the occlusive bandage before it was put in place, every 2 or 3 days over a 15-day period. The treated occlusive bandage was left in place between each application. After a period of 12 days without treatment, the challenge administration was performed by occlusive epicutaneous treatment with 0.5 ml of liquefied HFC-134a. No evidence of skin sensitisation was observed.
Migrated from Short description of key information:
In accordance with section 2 of REACH Annex XI, the study on skin sensitisation need not be condcuted as the substance is a gas. No evidence for skin sensitisation was observed in a non-standard study with HFC 134a in the Guinea pig.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
There was no evidence of respiratory sensitisation in repeated inhalation studies in animals up to 2 years. Additionally, there is no evidence of respiratory sensitisation in humans occupationally exposed to HFC 134a..
Migrated from Short description of key information:
There was no evidence of respiratory sensitisation in repeated inhalation studies in animals up to 2 years. Additionally, there is no evidence of respiratory sensitisation in humans occupationally exposed to HFC 134a.
Justification for classification or non-classification
The gaseous nature of HFC 134a precludes the conductance of conventional skin sensitisation study in animals. In an study using a non-standard protocol there was non-evidence of skin sensitisation in the Guinea pig. Additionally, extensive inhalation studies and human occupational exposure show no evidence of respiratory sensitisation. Therefore, classification for skin and respiratory senstisation is not warranted under EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
